Truist Financial Has Lowered Expectations for Omega Healthcare Investors (NYSE:OHI) Stock Price

Omega Healthcare Investors (NYSE:OHI) had its target price decreased by equities researchers at Truist Financial from $48.00 to $46.00 in a report released on Tuesday,Benzinga reports. The brokerage presently has a “hold” rating on the real estate investment trust’s stock. Truist Financial’s price target would indicate a potential upside of 2.25% from the company’s current price.

Several other brokerages have also commented on OHI. UBS Group raised their price target on shares of Omega Healthcare Investors from $52.00 to $54.00 and gave the company a “buy” rating in a research note on Wednesday, May 13th. Wells Fargo & Company raised their price target on shares of Omega Healthcare Investors from $47.00 to $49.00 and gave the company an “equal weight” rating in a research note on Monday, June 1st. BMO Capital Markets reiterated a “market perform” rating and set a $52.00 price objective on shares of Omega Healthcare Investors in a research note on Monday, May 4th. Scotiabank raised their price objective on shares of Omega Healthcare Investors from $48.00 to $50.00 and gave the company a “sector perform” rating in a research note on Thursday, May 21st. Finally, Royal Bank Of Canada raised their price objective on shares of Omega Healthcare Investors from $47.00 to $48.00 and gave the company a “sector perform” rating in a research note on Monday, May 4th. Six investment analysts have rated the stock with a Buy rating, seven have given a Hold rating and one has given a Sell rating to the stock. According to MarketBeat.com, the stock currently has a consensus rating of “Hold” and a consensus price target of $49.00.

Omega Healthcare Investors Stock Up 2.7%

NYSE OHI traded up $1.19 during trading hours on Tuesday, hitting $44.99. The company had a trading volume of 466,055 shares, compared to its average volume of 2,127,491. The company has a debt-to-equity ratio of 0.81, a current ratio of 5.32 and a quick ratio of 5.32. The firm’s 50 day moving average is $46.26 and its 200 day moving average is $45.72. The company has a market capitalization of $13.40 billion, a price-to-earnings ratio of 21.72, a P/E/G ratio of 1.91 and a beta of 0.58. Omega Healthcare Investors has a fifty-two week low of $35.70 and a fifty-two week high of $49.33.

Omega Healthcare Investors (NYSE:OHI) last released its quarterly earnings data on Tuesday, April 28th. The real estate investment trust reported $0.47 earnings per share for the quarter, missing the consensus estimate of $0.49 by ($0.02). Omega Healthcare Investors had a return on equity of 11.86% and a net margin of 51.14%.The business had revenue of $322.96 million for the quarter, compared to analyst estimates of $264.07 million. During the same quarter last year, the company earned $0.75 EPS. Omega Healthcare Investors’s revenue was up 16.7% compared to the same quarter last year. Omega Healthcare Investors has set its FY 2026 guidance at 3.190-3.250 EPS. Sell-side analysts anticipate that Omega Healthcare Investors will post 3.07 earnings per share for the current fiscal year.

Hedge Funds Weigh In On Omega Healthcare Investors

Several institutional investors and hedge funds have recently modified their holdings of OHI. Norges Bank purchased a new position in shares of Omega Healthcare Investors during the 4th quarter valued at $156,166,000. Invesco Ltd. grew its holdings in shares of Omega Healthcare Investors by 101.7% during the 3rd quarter. Invesco Ltd. now owns 4,944,921 shares of the real estate investment trust’s stock valued at $208,775,000 after acquiring an additional 2,493,877 shares in the last quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC acquired a new stake in shares of Omega Healthcare Investors in the 4th quarter valued at $93,476,000. Cbre Investment Management Listed Real Assets LLC lifted its stake in shares of Omega Healthcare Investors by 327.5% in the 4th quarter. Cbre Investment Management Listed Real Assets LLC now owns 2,222,799 shares of the real estate investment trust’s stock valued at $98,559,000 after purchasing an additional 1,702,846 shares during the last quarter. Finally, JPMorgan Chase & Co. lifted its stake in shares of Omega Healthcare Investors by 77.9% in the 3rd quarter. JPMorgan Chase & Co. now owns 3,417,240 shares of the real estate investment trust’s stock valued at $144,278,000 after purchasing an additional 1,496,059 shares during the last quarter. 65.25% of the stock is currently owned by hedge funds and other institutional investors.

About Omega Healthcare Investors

Omega Healthcare Investors, Inc is a real estate investment trust (REIT) that specializes in the ownership and management of healthcare-related facilities. The company’s core business involves acquiring and leasing long-term care properties, including skilled nursing facilities and assisted living communities, under net lease agreements. Its portfolio is designed to provide stable, inflation-protected cash flows from operators responsible for day-to-day property management.

Founded in 1992 and headquartered in Hunt Valley, Maryland, Omega Healthcare Investors has grown its holdings to encompass hundreds of facilities across the United States, with a smaller presence in select international markets.